Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Cardiol Therapeutics Inc (CRDL.TO)

Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis Newsfile - Tue Oct 22, 5:38AM CDT

MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra) and is expected to run concurrently with the Company's planned Phase...

CRDL.TO : 2.58 (-2.27%)
CRDL : 1.8700 (-2.09%)
Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option Newsfile - Fri Oct 11, 7:44AM CDT

Oakville, Ontario--(Newsfile Corp. - October 11, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.58 (-2.27%)
CRDL : 1.8700 (-2.09%)
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares Newsfile - Thu Oct 10, 8:16AM CDT

Oakville, Ontario--(Newsfile Corp. - October 10, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.58 (-2.27%)
CRDL : 1.8700 (-2.09%)
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares Newsfile - Wed Oct 9, 7:12AM CDT

Oakville, Ontario--(Newsfile Corp. - October 9, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.58 (-2.27%)
CRDL : 1.8700 (-2.09%)
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares Newsfile - Tue Oct 8, 3:12PM CDT

Toronto, Ontario--(Newsfile Corp. - October 8, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.58 (-2.27%)
CRDL : 1.8700 (-2.09%)
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis Newsfile - Tue Sep 24, 6:44AM CDT

Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.58 (-2.27%)
CRDL : 1.8700 (-2.09%)
Stocks in play: Cardiol Therapeutics Inc Baystreet - Tue Sep 10, 9:01AM CDT

Announced the data from its Phase II open-label MAvERIC-Pilot study investigating the impact of CardiolRx™ ...

CRDL.TO : 2.58 (-2.27%)
Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024 Newsfile - Tue Sep 10, 6:40AM CDT

Full clinical data will be reported in an oral presentation at the premier global event for advancements in cardiovascular science and medicine on November 18, 2024Toronto, Ontario--(Newsfile Corp. - September...

CRDL : 1.8700 (-2.09%)
CRDL.TO : 2.58 (-2.27%)
Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders Newsfile - Thu Jun 27, 11:34AM CDT

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL : 1.8700 (-2.09%)
CRDL.TO : 2.58 (-2.27%)
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT Newsfile - Tue Jun 25, 6:30AM CDT

Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL : 1.8700 (-2.09%)
CRDL.TO : 2.58 (-2.27%)

Barchart Exclusives

2 Dividend Aristocrats to Buy Hand Over Fist as Markets Price in a Trump Presidency Barchart - Tue Oct 22, 6:30PM CDT
Some analysts believe that stock markets are pricing a Trump victory in the upcoming U.S. presidential elections. Nucor and ExxonMobil look like two Dividend Aristocrats to buy for investors looking to bet on a second Trump presidency. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot